Brief: Vincerx Pharma Reports First Quarter 2023 Financial Results And Provides Corporate Update
11/05/2023 21:48
Vincerx Pharma Inc VINC.O :
* VINCERX PHARMA REPORTS FIRST QUARTER 2023 FINANCIAL
RESULTS AND
PROVIDES CORPORATE UPDATE
* VINCERX PHARMA INC - CASH BALANCE EXPECTED TO SUPPORT
PLANNED
OPERATIONS INTO LATE 2024
* VINCERX PHARMA INC - HAD ABOUT $39.8 MILLION IN CASH, CASH
EQUIVALENTS AND MARKETABLE SECURITIES AS OF MARCH 31, 2023
* VINCERX PHARMA INC - QTRLY LOSS PER SHARE $0.68
Source text for Eikon: ID:nGNXzFPys
Further company coverage: VINC.O
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign